Clinical Trial Update: GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing GI safety of celecoxib versus non-selective NSAIDs in osteoarthritis; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Osteoarthritis | Phase 4 | Status: COMPLETED | Results posted: 2011-11-30